Cellavision Ab · OMXSTO:CEVI
Cellavision Ab — Shareholder Meeting (April 2013)
24 slides from Cellavision Ab's shareholder meeting presentation, Apr 24, 2013
Slide 1: CellaVision Annual General Meeting 2013
CellaVision Annual General Meeting 2013 1 4/24/2013
Slide 2: The automated testing process
The automated testing process Sample Analysis by Samples which taken. cell counter. show signs of disease are sent on for further analysis in CellaVision’s analyzer. 2 4/24/2013
Slide 3: World leading supplier of digital solutions for blood and body fluids analyses
World leading supplier of digital solutions for blood and body fluids analyses The hematology market • 1.3 billion blood cell analyses in cell counter a year. • About 15 percent of these samples require microscopy. CellaVision’s global market potential • About 15,000 laboratories. • Global cell coun
Slide 4: CellaVision in short
CellaVision in short • Headquarters in Lund, Sweden. • Manufacturing outsourced to • 66 employees. Kitron AB, Sweden. • Sales through distributors. • Competition: manual Direct sales through microscopy and competing subsidiaries in the Nordic products in early phase. countries, the US, Canada and Ja
Slide 5: Market drivers: Higher cost pressure and competency shortages
Market drivers: Higher cost pressure and competency shortages • Customers mainly in Europe and North America but also in countries like Japan and China. • Hospital and commercial hematology laboratories • The hospital demand for efficiency and cost reduction makes automation the obvious choice • The
Slide 6: Our unique technology adds value
Our unique technology adds value • Efficiency cost reduction, increased productivity and shorter response times • Proficiency increased quality of results • Connectivity between sites; enhanced opportunity for collaboration and sharing of competences 6 4/24/2013
Slide 7: CASE: Cincinnati Children’s Hospital, USA
CASE: Cincinnati Children’s Hospital, USA
Slide 8: CASE: Xijing sjukhuset, Xi’an, China
CASE: Xijing sjukhuset, Xi’an, China 8 4/24/2013
Slide 9: Product offering
Product offering Analyzers, program and a minor part consumables 9 4/24/2013
Slide 10: 2012 in short
- 2012 in short 10 4/24/2013 2012 IN SHORT CellaVision develops and sells digital solutions for medical microscopy and is now a world leader in hematology, the study of blood. CellaVision’s products and solutions replace manual microscopes with analyzers based on digital image analysis technology, a
Slide 11: 2012: Growth: 9%. Operating Margin: 12%.
2012: Growth: 9 %. Operating Margin: 12%. Sales 180 30 EBIT Personell 160 25 140 120 20 100 Sales, MSEK 15 Personell, end of period 80 EBIT, MSEK 60 10 40 5 20 0 0 07 08 09 10 11 12 11 4/24/2013
Slide 12: 2012: Strengthened market position
2012: Strengthened market position Full year Full year MSEK 2012 2011 Net sales +9% 169,5 155,4 Gross profit 110,1 101,4 Operating profit 20,7 17,8 Operating margin % 12,2 11,5 Profit before tax 18,6 18,5 Cash flow -10,6 21,0
Slide 13: Key ratios Q1 2013
Key ratios Q1 2013 Q1 Q1 Full year MSEK 2013 2012 2012 Net sales -16% 33,8 40,4 +9% 169,5 Gross profit 22,0 27,1 110,1 Operating profit -0,7 5,4 20,7 Operating margin % Neg. 13,4 12,2 Profit before tax -1,5 4,4 18,6 Cash flow 6,3 -0,3 -10,6
Slide 14: Sales per quarter and geographical market
Sales per quarter and geographical market Quarterly variations continue 33,8 14 4/24/2013
Slide 15: 2013: More sales channels increase our growth opportunities
2013: More sales channels increase our growth opportunities Market expansion on both existing and new markets: • Siemens sales activities started. • European distribution agreements with two more partners. 15 4/24/2013
Slide 16: 2013: Strengthened product portfolio
2013: Strengthened product portfolio CellaVision® Proficiency Software • Product for internal and external quality assurance and proficiency testing of laboratory analyses. • Make proficiency testing easier, faster and more standardized. • Access and educate at the same time. • Evaluated by the Swed
Slide 17: 2013: Strengthened product portfolio (cont'd.)
2013: Strengthened product portfolio (cont'd.) DI‐60 • CellaVision’s technology integrated with Sysmex’ automated hematology line: Cell counter – Slidemaker stainer – CellaVision • Unique product – further streamlining the hematology workflow and providing highest testing efficiency. • Eliminating t
Slide 18: Outlook 2013
Outlook 2013 • Interest in our products and our position in the market has never been stronger. • However, the continuing weak world economy is delaying the hospital laboratories' purchases of equipment which impacts on our distributors' demand. Uncertainty in the market affects us and we expect low
Slide 19: Five foundations for continued growth
Five foundations for continued growth 1. Global expansion both existing and new gegraphical markets. 2. Partnerships strong, global sales channels 3. Continued product development resources 4. Customer relations close to partners and end customers 5. Company culture Initiative and responsibility 19
Slide 20: Sustainability report
Sustainability report – Corporate social responsibility Strategic HR • Core values • The customer in focus • Initiative and responsibility • Simplicity and quality • Code of Conduct • Environmental work – ISO 14001 • Support in the community 20 4/24/2013
Slide 21: Shareholders
Shareholders Shareholders % 1900 Number of shareholders 1704 Stiftelsen Industrifonden 15,0 1700 1635 Metallica Invest AB 10,2 1500 1444 Christer Fåhraeus m bolag 10,1 1300 Lannebo Fonder 4,6 1100 878 Livförsäkrings AB Skandia 4,1 900 763 675 701 Anders Althin 3,6 700 SSB and Trust Omnibus, OM14 3,4
Slide 22: Share performance 2009-2013
Share performance 2009‐2013 22 4/24/2013
Slide 23: Board and Management
Board and Management Management Board Yvonne Mårtensson Sven‐Åke Henningsson VP QA – vacancy Lars Gatenbeck Christer Fåhraeus Sven‐Åke Henningsson CEO Acting CFO Ordförande Stefan Bengtsson Karin Dahllöf Ron Hagner Lars Henriksson Roger Johanson Anna Malm Bernsten COO VP Sales & Marketing VP Busines
Slide 24: Learn more!
Learn more! • Web: www.cellavision.com • Blog: http://blog.cellavision.com • App: CellAtlas® – 60,000 users! 24 4/24/2013